{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:06:49Z","timestamp":1790381209657,"version":"4.1.0"},"reference-count":19,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2011,3,15]],"date-time":"2011-03-15T00:00:00Z","timestamp":1300147200000},"content-version":"vor","delay-in-days":73,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Laboratory Analysis"],"published-print":{"date-parts":[[2011,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Background<\/jats:italic>: Vitiligo is an acquired depigmenting disorder caused by the destruction of melanocytes. The exact etiopathogenesis and mechanisms of vitiligo are not fully understood. Vitamin B12 and folic acid levels are decreased in vitiligo, which are the important cofactors required in the metabolism of Homocysteine (Hcy). Consequently, Hcy level increases in the circulation. Therefore, it is possible that increased Hcy plays a role in melanocytes destruction. The aim was to study for any association of vitiligo with serum Hcy level. <jats:italic>Method<\/jats:italic>: A total of 30 vitiligo patients of both sexes and 30 control subjects were enrolled in this study. Sera from patients and controls were assayed for Hcy by Enzyme immunoassay. The collected data were analyzed by SPSS version\u201016. <jats:italic>Results<\/jats:italic>: The mean serum level of Hcy was significantly higher in patients with vitiligo as compared with healthy controls and its level was high in male patients as compared with female patients. The Hcy level in vegetarian patients was significantly higher as compared with nonvegetarian patients. The Hcy level was also significantly higher in active vitiligo patients as compared with stable vitiligo patients. <jats:italic>Conclusion<\/jats:italic>: An increased serum Hcy may be a precipitating factor for vitiligo in the predisposed individuals. Serum Hcy is related to the gender of patients, activity of disease, and dietary habits of vitiligo patients. J. Clin. Lab. Anal. 25:110\u2013112, 2011. \u00a9 2011 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/jcla.20442","type":"journal-article","created":{"date-parts":[[2011,3,15]],"date-time":"2011-03-15T20:36:50Z","timestamp":1300221410000},"page":"110-112","source":"Crossref","is-referenced-by-count":27,"title":["Increased level of serum Homocysteine in vitiligo"],"prefix":"10.1002","volume":"25","author":[{"given":"Suman","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam Sunder","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,3,15]]},"reference":[{"key":"e_1_2_7_2_2","first-page":"68","article-title":"High frequency of thyroid dysfunction in Indian patients with vitiligo","volume":"48","author":"Dave S","year":"2003","journal-title":"Indian J Dermatol"},{"key":"e_1_2_7_3_2","first-page":"39","article-title":"Folic acid and vitamin B12 in vitiligo: A nutritional approach","volume":"50","author":"Montes LF","year":"1992","journal-title":"Cutis"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.1999.40.3.195"},{"key":"e_1_2_7_5_2","first-page":"77","article-title":"Serum levels of vitamin B12 and folic acid in Egyptian patients with vitiligo","volume":"21","author":"El\u2010Batawi MMY","year":"2001","journal-title":"Egypt J Derm Androl"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/heart.83.2.127"},{"key":"e_1_2_7_7_2","first-page":"1279","volume-title":"The Metabolic and Molecular Basis of Inherited Disease","author":"Mudd SH","year":"1995"},{"key":"e_1_2_7_8_2","first-page":"1","article-title":"Homocysteine, the new marker of disease risk: An overview","author":"Gouaille CB","year":"2005","journal-title":"Eur Pharmacother"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08712.x"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0369-8114(03)00104-4"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1996.d01-727.x"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2006.050769"},{"key":"e_1_2_7_13_2","first-page":"127","article-title":"Tyrosinase inhibition due to interaction of homocysteine with copper: The mechanism for reversible hypopigmentation in homocystinuria due to cystathionine beta\u2010synthase deficiency","volume":"57","author":"Reish O","year":"1995","journal-title":"Am J Hum Genet"},{"key":"e_1_2_7_14_2","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/ajcn\/63.2.194","article-title":"Kinetics of total plasma homocysteine in subjects with hyperhomocysteinemia due to folate or cobalamin deficiency","volume":"64","author":"Guttormsen AB","year":"1996","journal-title":"Am J Clin Nutr"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/72.3.751"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-0495(97)90248-1"},{"key":"e_1_2_7_17_2","first-page":"945","article-title":"Study on the distribution of serum homocysteine and on multi\u2010stepwise regression analysis of the associated factors in the population of community areas in Wuhan [In Chinese]","volume":"25","author":"Hu CP","year":"2004","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclnm.2007.08.004"},{"key":"e_1_2_7_19_2","first-page":"402","volume-title":"Modern Nutrition in Health and Disease","author":"Herbert V","year":"1994"},{"key":"e_1_2_7_20_2","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1684\/ejd.2009.0671","article-title":"Serum homocysteine, folic acid and vitamin B12 levels in vitiligo","volume":"19","author":"Balci DD","year":"2009","journal-title":"Eur J of Dermatol"}],"container-title":["Journal of Clinical Laboratory Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcla.20442","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcla.20442","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,8]],"date-time":"2023-10-08T21:06:11Z","timestamp":1696799171000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcla.20442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["10.1002\/jcla.20442"],"URL":"https:\/\/doi.org\/10.1002\/jcla.20442","archive":["Portico"],"relation":{},"ISSN":["0887-8013","1098-2825"],"issn-type":[{"value":"0887-8013","type":"print"},{"value":"1098-2825","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}